Hellp syndrome anaesthesia

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have sufficient information from authoritative sources to provide a comprehensive answer. Let me compile everything.

HELLP Syndrome: Anaesthetic Management

What is HELLP Syndrome?

HELLP (Haemolysis, Elevated Liver enzymes, Low Platelets) is considered a variant of preeclampsia with severe features. Key features:
  • H — Haemolysis (microangiopathic)
  • EL — Elevated liver enzymes (AST/ALT; rarely exceed 500 IU/L)
  • LP — Low platelets (<100,000/mm³)
Severe hypertension may be absent in some cases. Occurs in ~10% of severe preeclampsia cases. Importantly, 20% of cases develop postpartum, so surveillance continues after delivery.

Anaesthetic Considerations

1. Pre-operative Assessment

ParameterSignificance
Platelet countCritical before any neuraxial technique
Liver enzymesAltered drug metabolism, coagulopathy risk
Coagulation screenDIC can complicate HELLP
AirwayOedema from preeclampsia/magnesium; full obstetric airway assessment
Blood pressureTarget SBP <160 mmHg, DBP <110 mmHg
Renal functionCreatinine >1.1 mg/dL or doubling = severe feature
Serum magnesiumIf on therapy — potentiates neuromuscular blockade

2. Regional vs. General Anaesthesia

Regional anaesthesia is the preferred technique for labour and delivery in preeclampsia/HELLP, provided coagulopathy permits.
Advantages of neuraxial anaesthesia:
  • Best quality pain relief
  • Attenuates hypertensive responses to pain
  • Reduces circulating catecholamines
  • Does not require fluid preload with dilute local anaesthetic/opioid solutions
  • Avoids the hazards of general anaesthesia (difficult airway, aspiration, hypertensive response to laryngoscopy)
"Regional anesthesia is the preferred technique for patients with preeclampsia for labor and delivery." — Miller's Anesthesia, 10e

3. Platelet Thresholds for Neuraxial Anaesthesia

This is the most critical anaesthetic issue in HELLP syndrome:
Platelet CountNeuraxial RiskRecommendation
≥70,000/mm³Very low riskSafe; recommended threshold for obstetric neuraxial (SOAP consensus)
50,000–69,000/mm³~3% upper bound for epidural haematomaIndividualised decision
<50,000/mm³Up to 11% riskGenerally avoided; consider GA
"The SOAP interdisciplinary consensus statement on neuraxial procedures in patients with thrombocytopenia concluded the best available evidence indicates a very low risk of neuraxial hematoma was associated with a platelet count of ≥70,000/mm³." — Miller's Anesthesia, 10e
  • The older threshold of 100,000/mm³ has been challenged; 70,000/mm³ is now the accepted safe threshold for obstetric neuraxial procedures
  • There is no universally accepted platelet count; decision must incorporate rate of fall, trend, other coagulation abnormalities, and clinical context
  • No single platelet function test reliably predicts bleeding risk after regional anaesthesia

4. General Anaesthesia — When Required

Indications: platelet count <70,000/mm³, active coagulopathy, DIC, patient refusal of regional, or failed regional.
Key concerns:
  • Difficult/failed intubation: Increased risk in obstetrics; airway oedema is worsened in preeclampsia. A clear algorithm for failed intubation must be in place.
  • Aspiration risk: Full stomach; RSI with cricoid pressure
  • Hypertensive response to laryngoscopy: Dangerous in these patients — blunt with remifentanil, esmolol, lignocaine, or magnesium bolus
  • Magnesium interactions:
    • Potentiates non-depolarising neuromuscular blockers — reduce dose and monitor with nerve stimulator
    • Suxamethonium may have prolonged action — reduced pseudocholinesterase activity is reported in HELLP syndrome
  • Succinylcholine: Reduced plasma pseudocholinesterase activity documented in HELLP syndrome may prolong block
  • Volatile agents: Avoid in the presence of coagulopathy/DIC if possible (may worsen uterine atony)

5. Blood Pressure Management

  • Treat SBP ≥160 mmHg or DBP ≥110 mmHg to prevent intracerebral haemorrhage, myocardial ischaemia, renal injury, and heart failure
  • First-line agents: IV labetalol, IV hydralazine, oral nifedipine
  • Patients with HELLP/preeclampsia are sensitive to both endogenous and exogenous catecholamines — careful use of vasopressors
  • Methergonovine (ergometrine) is contraindicated — may cause hypertensive crisis; use oxytocin for uterotonic management instead

6. Fluid Management

  • Maternal vasculature in preeclampsia is contracted (vasospasm) but porous (endothelial damage) — not simply underfilled
  • Aggressive IV fluid administration risks pulmonary oedema (already a severe feature)
  • Conservative fluid management: avoid large preloads; use vasopressors (phenylephrine/ephedrine) judiciously for regional-induced hypotension
  • Phenylephrine is associated with less foetal acidosis than ephedrine but requires caution given catecholamine sensitivity

7. Magnesium Sulphate

  • Indicated for seizure prophylaxis (eclampsia prevention) in preeclampsia/HELLP
  • Anaesthetic implications:
    • Potentiates neuromuscular blockade — monitor TOF; use reduced doses of NDMR
    • May worsen postpartum uterine atony — have oxytocin and additional uterotonics ready
    • Side effects: respiratory depression, loss of deep tendon reflexes (early sign of toxicity), cardiac arrest at very high levels
    • Antidote: calcium gluconate 1g IV

8. Delivery and Postpartum

  • HELLP is an indication for delivery but not necessarily caesarean section — vaginal delivery is acceptable if feasible
  • Laboratory abnormalities typically improve within 5 days postpartum, though they may initially worsen
  • 20% of HELLP cases develop postpartum — continue monitoring liver enzymes, platelets, and BP after delivery
  • If epidural catheter was placed, consider timing of removal carefully against platelet trend (recheck count before removal)

9. Summary of Key Anaesthetic Priorities

  1. Check and trend platelets — determines regional vs. general approach
  2. Neuraxial preferred if platelets ≥70,000/mm³ and no active coagulopathy
  3. Control blood pressure before induction/intubation
  4. Prepare for difficult airway — always
  5. Account for magnesium — adjust NDMR dosing, monitor TOF
  6. Avoid Methergine — use oxytocin for uterotonic management
  7. Conservative fluid strategy — pulmonary oedema risk
  8. Postpartum surveillance continues — HELLP can develop or worsen after delivery

Sources: Miller's Anesthesia, 10e; Creasy & Resnik's Maternal–Fetal Medicine, 8e
This is a shared conversation. Sign in to Orris to start your own chat.